A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy

ClinicalTrials.gov ID: NCT00451958

Public ClinicalTrials.gov record NCT00451958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients With Prostate Cancer Requiring Androgen Ablation Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Participants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study. The study continued until all non-discontinued participants had received treatment for at least 5 years.

Study identification

NCT ID: NCT00451958
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Ferring Pharmaceuticals; Industry
Enrollment: 386 participants

Conditions and interventions

Conditions

Prostate Cancer

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Male
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 2007 (Type not available)
Primary completion: Oct 2011 (Actual)
Completion: Dec 2011 (Actual)
Last update posted: Mar 21, 2013

2007 – 2011

United States locations

U.S. sites: 14
U.S. states: 11
U.S. cities: 14

Facility	City	State	ZIP	Site status
Urology Centers Of Alabama	Homewood	Alabama	—	—
South Orange County Medical Research Center	Laguna Hills	California	—	—
Western Clinical Research	Torrance	California	—	—
Urology Associates Research	Englewood	Colorado	—	—
South Florida Medical Research	Aventura	Florida	—	—
Investigational Site	Ocala	Florida	—	—
Regional Urology	Shreveport	Louisiana	—	—
Lawrenceville Urology	Lawrenceville	New Jersey	—	—
Investigational Site	Carmel	New York	—	—
North Urology Research	Concord	North Carolina	—	—
Investigational Site	Greensboro	North Carolina	—	—
State College Urologic Association	State College	Pennsylvania	—	—
Urology San Antonio Research	San Antonio	Texas	—	—
Seattle Urology Research Center	Burien	Washington	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00451958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 21, 2013 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00451958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →